Project Grant R15NS149247
- The National Institute of Neurological Disorders and Stroke awarded The General Hospital Corporation (Massachusetts General Hospital) $629,733 on August 15, 2026, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853) to support research into the mechanisms of magnetic activation of neurons. The research combines engineering, electrophysiological recordings, and computational modeling to systematically study how induced electromagnetic fields...
- The National Institute of Mental Health awarded Trustees of Dartmouth College $114,152 on September 1, 2026, under the Mental Health Research Grants program (CFDA 93.242) to support research determining and enhancing the cellular selectivity of transcranial magnetic stimulation using optical physiology and computational models. The funded research directly tests predictions about how transcranial magnetic stimulation (TMS)—an FDA-approved treatment for drug-resistant depression,...
- Federal Project Grant Award Summary Magnetic Tides, Inc. received a $936,787 Project Grant from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853), effective September 1, 2025, through August 31, 2028. The award funds development and validation of Kilohertz Transcranial Magnetic Perturbation (KTMP), a novel non-invasive brain stimulation technology designed to enhance...
- The National Institute of Mental Health awarded The Leland Stanford Junior University $1,066,793 under the Mental Health Research Grants program (CFDA 93.242) on April 1, 2026, to develop and validate a personalized repetitive transcranial magnetic stimulation (rTMS) protocol for treatment-resistant depression using electrophysiological biomarkers. The award funds an R61/R33 phased study that will use early local TMS-evoked potentials (EL-TEPs)—measurements of prefrontal excitability—to...
- The National Institute of Neurological Disorders and Stroke awarded Emory University $635,512 on September 1, 2026, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853) to develop and validate an automated deep brain stimulation programming platform for patients with Parkinson's disease. The project will develop machine learning algorithms and a closed-loop automated system to optimize deep brain stimulation parameters—including contact...
- The federal Project Grant award R21NS137987, in the amount of $427,625.00, was provided by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program. The award supports research at the University of Iowa to investigate whether the Transcranial Magnetic Stimulation (TMS)-evoked potential (TEP) in EEG recordings can serve as a non-invasive measure of cortical excitability during...
- The National Institute of Neurological Disorders and Stroke awarded New Jersey Institute of Technology $559,641 on September 1, 2026, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853). NJIT is developing ultrasound-activated therapeutic gas microbubbles for treatment of mild traumatic brain injury induced by repetitive low-level blasts. The research targets military, law enforcement, veterans, and civilian personnel exposed repeatedly to...
- The National Institute of Mental Health awarded Massachusetts General Hospital $453,750 under the Mental Health Research Grants program (CFDA 93.242) on September 1, 2026, to develop a closed-loop system for assessing target network engagement using concurrent transcranial magnetic stimulation and functional MRI. The recipient is developing a flexible radiofrequency coil array (the RF Cap) that enables functional MRI acquisition simultaneously with transcranial magnetic stimulation in a...
- The National Institute of Neurological Disorders and Stroke awarded New Jersey Institute of Technology $553,292 on March 11, 2026, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853) to engineer an in vitro three-dimensional tissue construct for studying peripheral nerve regeneration. The recipient will develop 3D hollow channel systems seeded with embryonic dorsal root ganglia explants and coated with specific extracellular matrix...
- The National Institute of Neurological Disorders and Stroke awarded Emory University $618,523 under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853) on September 1, 2026, for research on scalable, affordable artificial intelligence-driven clinical decision support for movement disorders. The project addresses misdiagnosis and access barriers in Parkinson's disease care, particularly the underdiagnosis of psychiatric symptoms and limited...
The National Institute of Neurological Disorders and Stroke awarded New Jersey Institute of Technology $558,167 on July 25, 2026, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853) to develop an AI-driven robotic transcranial magnetic stimulation (TMS) system for high-resolution cortical mapping. The project addresses spatial inaccuracy in conventional manual TMS systems, which typically introduce positioning errors exceeding 5–11 millimeters across sessions and create operator dependence that compromises cortical mapping reliability. The recipient will engineer a six-degree-of-freedom robotic arm integrated with a closed-loop Gaussian-process Bayesian optimization algorithm that uses motor-evoked potential feedback to automatically position and adjust the TMS coil in real time. The system targets 2 millimeter spatial and 2-degree orientation precision—a tenfold improvement over manual methods—and aims to reduce stimulation requirements by 4–5 times, decreasing motor hotspot localization pulses from approximately 50–100 to 17. The project comprises three specific aims: development of the robotic TMS coil holder with integrated safety systems and brain phantoms for validation; implementation of the Bayesian optimization algorithm; and validation of cortical mapping performance using sophisticated brain phantoms that simulate motor-evoked potential responses. Phantom-based validation will enable comprehensive system characterization under controlled conditions while establishing the foundation for future human studies applications. The award provides immersive research training for three undergraduate students. Performance occurs in New Jersey, with a period of performance extending from July 25, 2026, through June 30, 2029.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $558.2k | 7/27/26 |